InfuSystem Holdings, Inc (NYSE: INFU)

InfuSystem Holdings, Inc. operates as a leading national healthcare service provider, specializing in facilitating outpatient care for Durable Medical Equipment (DME) manufacturers and healthcare providers. The company's core business activities revolve around providing products and services to hospitals, oncology practices, ambulatory surgery centers, and other alternate site healthcare providers. InfuSystem Holdings, Inc. operates through its subsidiary, InfuSystem, Inc., and maintains its headquarters in Rochester Hills, Michigan, with operations across seven locations in the United States and Canada.

The company generates revenue through a two-platform model: Patient Services and Device Solutions. Patient Services focuses on providing last-mile solutions for clinic-to-home healthcare, involving complex DME and related services. This platform includes the supply of electronic ambulatory infusion pumps and associated disposable supply kits, primarily for the treatment of various cancers, including colorectal cancer. Device Solutions complements Patient Services by offering equipment rental and sales, consumable sales, and biomedical support services. The company's revenue streams are further bolstered by its extensive network of third-party payer contracts, which as of December 31, 2025, included nearly 840 networks.

• Patient Services: This segment is the lead platform of InfuSystem Holdings, Inc., providing turnkey solutions designed to implement without service disruptions. The segment offers electronic ambulatory infusion pumps and associated disposable supply kits, primarily for the treatment of oncology-related conditions. Key services include order and delivery logistics, 24/7 nursing support, third-party payer billing, and biomedical services for the DME. The segment also focuses on pain management and wound care, offering services such as continuous peripheral nerve block (CPNB) for post-operative pain management and Negative Pressure Wound Therapy (NPWT) devices. Additionally, the segment engages in acquisitions and partnerships to expand its service offerings and market reach.

• Device Solutions: This platform provides incremental services to healthcare provider customers on a direct payer model. Services include equipment rental and sales, consumable sales, and biomedical recertification, maintenance, and repair services. The segment caters to oncology practices, hospitals, and other clinical settings, offering a range of pole-mounted and ambulatory infusion pumps for rental or sale. The segment also provides treatment-related consumables and biomedical services for various healthcare settings, including acute care facilities, home care providers, skilled nursing facilities, and pain centers.

InfuSystem Holdings, Inc. holds a strong position within the healthcare service industry, particularly in the DME sector. The company competes with national, regional, and hospital-owned DME providers, as well as physician providers and home care infusion providers. Key competitors include national providers offering similar third-party reimbursement, rental, and sale of infusion pumps and related products. Regional DME providers and hospital-owned providers also compete in this space, though they typically have limited resources and third-party payer contracts. Physician providers and home care infusion providers offer additional competition, with varying levels of service and cost structures.

The company's competitive advantages include its longstanding participation and strong reputation in the DME space, well-established relationships with DME manufacturers and healthcare provider customers, and high levels of service. InfuSystem Holdings, Inc. benefits from economies of scale, a large pump fleet, seven geographic locations allowing for same-day or next-day delivery, and a team of field-based and traveling biomedical technicians. The company's extensive network of third-party payer contracts and investments in information technology further enhance its competitive position.

InfuSystem Holdings, Inc. serves a broad customer base, including hospitals, oncology practices, ambulatory surgery centers, and other alternate site healthcare providers. The company has established contracts with nearly 840 third-party payer networks as of December 31, 2025, ensuring that reimbursement is not a significant obstacle for providers recommending continuous infusion therapy. The customer base also includes various other third-party payer organizations, Medicaid, commercial Medicare replacement plans, self-insured plans, facilities of Medicare patients, and numerous other insurance carriers. The company's relationships with clinical oncologists in approximately 2,100 outpatient oncology clinics further demonstrate its extensive market reach and customer base.